Eucope Visual

EUCOPE Press releases

EUCOPE and other associations representing the European and British life science industry launch a joint policy document on the potential impact of the UK’s exiting the EU

Thursday, December 14th, 2017 in News Press Releases

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting the European Union. Today, organisations representing the life science industry in ... read more...

European health community calls on the EU and UK to prioritise patients as crunch Article 50 decision approaches

Thursday, December 7th, 2017 in News Press Releases

Today a group of organisations representing patients, healthcare professionals and the health care industry have called on the EU and UK to prioritise patients in the Brexit negotiations. To coincide with the EPSCO Council of EU Health Ministers in Brussels, this policy statement comes just one week ahead of the crunch ... read more...

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit

Tuesday, November 28th, 2017 in News Press Releases

The associations representing the European and British life science industry (AESGP, EFPIA, EuropaBio, EUCOPE, Medicines for Europe, ABPI, BGMA, BIA, PAGB) have today underlined the importance of securing cooperation between the UK and EU on medicines regulation. Whilst we respect the phased approach of negotiations, we urge progress to be made ... read more...

EUCOPE-EURORDIS Press Release on Recommendations on Orphan Medicines Pricing and Reimbursement

Monday, March 13th, 2017 in News Newsletter Press Releases

Expert Group Publishes Recommendations on Orphan Medicines Pricing and Reimbursement Brussels,13th March 2017. Rare diseases are a major public health issue. Despite new legislation to support the authorization of orphan medicinal products to treat rare diseases, many products do not reach patients in time, leading to continued decline in quality ... read more...

EUCOPE, EFPIA and EuropaBio welcome the Publication of the European Commission’s Study on Off-Label Use and call for policy measures that preserve patients’ safety and the integrity of the EU regulatory regime

Thursday, March 2nd, 2017 in News Newsletter Press Releases

The Associations welcome the European Commission’s decision to publish the results of its study on off-label use in the EU as an effort to offer clarity and transparency in relation to this practice. The report provides useful information on the drivers of off-label use. In particular, it acknowledges that, beyond purely ... read more...